Christopher Fuglesang serves as Executive at Mirati Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Fuglesang has executed 12 insider transactions totaling $95.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 1, 2021 involved transacting 23,622 shares valued at $1.4M.
Christopher Fuglesang currently holds 216,288 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Fuglesang has been a net seller of MRTX stock. They have purchased $14.6M and sold $80.8M worth of shares.
Christopher Fuglesang's most recent insider trade was on Apr 1, 2021, when they sold 23,622 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| $60.00 |
| Discretionary |
| Oct 30, 2020 | MRTX | $7.5M | Sale | 37,050 | $202.00 | Discretionary |
| Oct 30, 2020 | MRTX | $440 | Payment | 2 | $219.97 | Discretionary |
| Oct 30, 2020 | MRTX | $0 | Option Exercise | 362,952 | $N/A | Discretionary |
| Oct 30, 2020 | MRTX | $73.3M | Sale | 362,950 | $202.00 | Discretionary |
| Oct 30, 2020 | MRTX | $220 | Payment | 1 | $219.97 | Discretionary |
| Oct 30, 2020 | MRTX | $0 | Option Exercise | 37,051 | $N/A | Discretionary |
| Jul 21, 2020 | PAND | $0 | Conversion | 1,408,913 | $N/A | Discretionary |
| Jul 21, 2020 | PAND | $13.0M | Purchase | 722,222 | $18.00 | Discretionary |
| Jan 6, 2017 | MRTX | $1.6M | Purchase | 280,059 | $5.60 | Discretionary |
| Jan 6, 2017 | MRTX | $34.2K | Purchase | 6,104 | $5.60 | Discretionary |